China Endometriosis Treatment Market Size & Outlook

The endometriosis treatment market in China is expected to reach a projected revenue of US$ 259.0 million by 2033. A compound annual growth rate of 12.7% is expected of China endometriosis treatment market from 2026 to 2033.
Revenue, 2025 (US$M)
$98.1
Forecast, 2033 (US$M)
$259.0
CAGR, 2026 - 2033
12.7%
Report Coverage
China

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

China endometriosis treatment market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

China endometriosis treatment market highlights

  • The China endometriosis treatment market generated a revenue of USD 86.1 million in 2024 and is expected to reach USD 189.6 million by 2030.
  • The China market is expected to grow at a CAGR of 14.1% from 2025 to 2030.
  • In terms of segment, hormone therapy was the largest revenue generating treatment type in 2024.
  • Hormone Therapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.

Endometriosis treatment market data book summary

Market revenue in 2024USD 86.1 million
Market revenue in 2030USD 189.6 million
Growth rate14.1% (CAGR from 2025 to 2030)
Largest segmentHormone therapy
Fastest growing segmentHormone Therapy
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPain Medication, Hormone Therapy
Key market players worldwideBayer AG, Pfizer Inc, AbbVie Inc, AstraZeneca PLC, ObsEva SA, Teva Pharmaceutical Industries Ltd, Zydus Lifesciences, Eli Lilly and Co, Astellas Pharma Inc

Other key industry trends

  • In terms of revenue, China accounted for 4.9% of the global endometriosis treatment market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China endometriosis treatment market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 95.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Endometriosis Treatment Market Companies

Name Profile # Employees HQ Website
ObsEva SA View profile 27 Chemin des Aulx, 12, Plan-les-Ouates, Geneva, Switzerland, 1228 https://www.obseva.com
Zydus Lifesciences View profile 10001+ Ahmedabad, Gujarat, India, Asia https://zyduslife.com/
Astellas Pharma Inc View profile 14484 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 http://www.astellas.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Eli Lilly and Co View profile 43000 Lilly Corporate Center, Indianapolis, IN, United States, 46285 https://www.lilly.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com

China endometriosis treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to endometriosis treatment market will help companies and investors design strategic landscapes.


Hormone therapy was the largest segment with a revenue share of 90.01% in 2025. Horizon Databook has segmented the China endometriosis treatment market based on pain medication, hormone therapy covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to China endometriosis treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China endometriosis treatment market databook

  • Our clientele includes a mix of endometriosis treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China endometriosis treatment market , including forecasts for subscribers. This country databook contains high-level insights into China endometriosis treatment market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China endometriosis treatment market report size, by treatment type, 2021-2033 (US$M)

China Endometriosis Treatment Market Outlook Share, 2025 & 2033 (US$M)

China endometriosis treatment market report size, by treatment type, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online